Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells
- PMID: 3731108
Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells
Abstract
MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma both contain sialomucin as a major cell surface component and are resistant to cytolysis by normal rat spleen lymphocytes [3 +/- 2% (SD) and 0 +/- 1%, respectively]. Susceptibility to lysis did not increase following treatment of cells with neuraminidase, fucosidase, or alpha- or beta-galactosidase. Treatment with trypsin significantly increased the susceptibility of MAT-B1 (14 +/- 3%) but not MAT-C1 (5 +/- 2%). Following 1 month in culture, the sialomucin content of MAT-B1 cells dropped from 30% to 8% (determined by glucosamine labeling) and natural cell-mediated cytolysis increased to 16 +/- 4%, whereas the sialomucin content and susceptibility of MAT-C1 cells did not change. The results indicate that the relatively minor changes associated with removal of cell surface sialic acid or fucose residues do not result in increased susceptibility of the ascites cells to cytolysis. However, susceptibility of MAT-B1 cells to lysis by normal rat spleen lymphocytes was inversely correlated with the amount of major glycoprotein (r = -0.96).
Similar articles
-
Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells.Cancer Res. 1990 Sep 1;50(17):5250-6. Cancer Res. 1990. PMID: 2386935
-
Sialomucin and lytic susceptibility of rat mammary tumor ascites cells.Cancer Res. 1990 Nov 1;50(21):6800-5. Cancer Res. 1990. PMID: 2208144
-
Sialyltransferase of the 13762 rat mammary ascites tumor cells.Cancer Res. 1984 Mar;44(3):1148-52. Cancer Res. 1984. PMID: 6692399
-
Relationship between xenotransplantability and cell surface properties of ascites sublines of a rat mammary adenocarcinoma.J Natl Cancer Inst. 1982 Jul;69(1):33-40. J Natl Cancer Inst. 1982. PMID: 6954321
-
Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity.Glycobiology. 1993 Jun;3(3):201-18. doi: 10.1093/glycob/3.3.201. Glycobiology. 1993. PMID: 8358147 Review. No abstract available.
Cited by
-
Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.PLoS Pathog. 2010 Sep 9;6(9):e1001098. doi: 10.1371/journal.ppat.1001098. PLoS Pathog. 2010. PMID: 20844579 Free PMC article.
-
Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen.Clin Exp Metastasis. 1991 May-Jun;9(3):283-99. doi: 10.1007/BF01753731. Clin Exp Metastasis. 1991. PMID: 1676354
-
The role of membrane mucin MUC4 in breast cancer metastasis.Endocr Relat Cancer. 2021 Nov 24;29(1):R17-R32. doi: 10.1530/ERC-21-0083. Endocr Relat Cancer. 2021. PMID: 34726614 Free PMC article. Review.
-
The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.J Cell Biol. 1994 Dec;127(6 Pt 2):2071-80. doi: 10.1083/jcb.127.6.2071. J Cell Biol. 1994. PMID: 7528749 Free PMC article.
-
C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components.Biochem J. 2002 Sep 1;366(Pt 2):623-31. doi: 10.1042/BJ20020289. Biochem J. 2002. PMID: 12027806 Free PMC article.